James R Sellers Selected Research

Stroke (Strokes)

1/2021	Myosin-Specific Adaptations of In vitro Fluorescence Microscopy-Based Motility Assays.
8/2014	Chaperone-enhanced purification of unconventional myosin 15, a molecular motor specialized for stereocilia protein trafficking.
3/2013	Mammalian myosin-18A, a highly divergent myosin.
1/2013	Kinetic characterization of nonmuscle myosin IIb at the single molecule level.
5/2010	Direct observation of the myosin-Va power stroke and its reversal.
9/2008	Direct observation of the mechanochemical coupling in myosin Va during processive movement.
1/2008	Kinetics of ADP dissociation from the trail and lead heads of actomyosin V following the power stroke.
10/2005	The predicted coiled-coil domain of myosin 10 forms a novel elongated domain that lengthens the head.
9/2005	Load-dependent kinetics of myosin-V can explain its high processivity.
12/2002	The prepower stroke conformation of myosin V.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James R Sellers Research Topics

Disease

11	Stroke (Strokes) 01/2021 - 01/2002
2	MYH9-Related Disorders 01/2020 - 11/2002
2	Arthrogryposis renal dysfunction cholestasis syndrome 01/2019 - 12/2017
1	Deafness (Deaf Mutism) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2020
1	Fibrosarcoma 11/2016
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2015
1	Rupture 01/2015
1	Central Nervous System Cavernous Hemangioma 01/2015
1	Hearing Loss (Hearing Impairment) 08/2014
1	Arthrogryposis 08/2013
1	Muscular Diseases (Myopathy) 08/2013
1	Heart Diseases (Heart Disease) 05/2013
1	Blindness (Hysterical Blindness) 04/2008
1	Usher Syndromes (Usher Syndrome) 04/2008
1	Nonsyndromic Deafness 04/2008
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2003

Drug/Important Bio-Agent (IBA)

7	Myosins (Myosin)IBA 01/2021 - 01/2002
4	Actins (F Actin)IBA 01/2021 - 09/2005
3	Adenosine Triphosphatases (ATPase)IBA 01/2021 - 01/2002
3	Myosin Type VIBA 09/2005 - 01/2002
2	Nonmuscle Myosin Type IIAIBA 01/2020 - 11/2002
2	ActomyosinIBA 08/2013 - 01/2008
2	Adenosine Triphosphate (ATP)IBA 03/2013 - 09/2008
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	rho-Associated KinasesIBA 01/2015
1	DEET (DET)IBA 08/2014
1	myosin-binding protein CIBA 08/2013
1	Cardiac MyosinsIBA 05/2013
1	Myosin SubfragmentsIBA 01/2013
1	NucleotidesIBA 04/2008
1	Myosin VIIaIBA 04/2008
1	Adenosine Diphosphate (ADP)IBA 01/2008
1	Ventricular MyosinsIBA 01/2003
1	Myosin Type IIIBA 12/2002